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Introduction: Sarcomas of the ovary can either be histologically pure or can represent components of a more
complex tumor. Ovarian angiosarcomas are rare, and probably arise from carcinosarcomas, teratomas or the rich
ovarian vasculature. To date, only two small case series have been published, one with four cases and the other
with seven.
Case presentation: A 41-year-old Saudi woman presented to our gynecological clinic with abnormal vaginal
bleeding. The initial clinical diagnosis was left ovarian cyst. The results of the remainder of her abdominopelvic
examination were normal. Peri-operatively, the left ovarian mass resembled a hemorrhagic solid tumor. It was
sent for frozen sectioning, which revealed it was an undifferentiated neoplasm. The final histopathological examination
showed a vascular neoplasm showing vasoformative arborizing channels of variable sizes and shapes lined by atypical
endothelial cells with intact capsule. Areas of necrosis were seen, along with fused anastomosing solid vascular area.
She was diagnosed as having an angiosarcoma of intermediate grade, International Federation of Gynecology and
Obstetrics stage IA.
Conclusions: Patients with ovarian angiosarcomas most commonly present with abdominal pain, however some
patients present with distant metastases, often in the lungs. Spread beyond the ovary is present at the time of diagnosis
in most reported cases, with disease progression within less than a year after diagnosis. Cases of advanced stage disease
behave aggressively and demonstrate poor response to surgery and chemotherapy, with an overall poor prognosis.
They have a tendency for local recurrence and metastases, and prognosis is hence poor; the reported five-year survival
rate is 10 percent to 35 percent, however, cases confined to the ovary have survived up to nine years.
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Soft tissue sarcomas account for less than 1 percent of all
malignancies. Gynecological sarcomas are rare and have
poor prognosis. Among gynecological sarcomas, uterine
sarcomas are the most common. Sarcomas of the ovary
comprise less than 1 percent of ovarian malignancies,
mostly seen as components of carcinosarcomas [1].
Angiosarcomas comprise only 2 percent of all soft tis-
sue sarcomas [2]. They can occur in cutaneous, deep soft
tissue, the breast, or visceral locations; cutaneous angio-
sarcoma in the head and neck region of older persons is
the most common type. Angiosarcoma of deep soft tis-
sue, except for the epithelioid variant, is very rare, and* Correspondence: nausheen_yaqoob@hotmail.com
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reproduction in any medium, provided the orthe prognosis almost always is poor. Visceral angiosar-
coma have been reported in the liver, spleen, adrenal
and thyroid glands, and heart, and less commonly in the
vagina, vulva, cervix and rarely the ovary, with appar-
ently fewer than 33 cases reported in the literature (al-
though the validity of a considerable number of cases
has been questioned).
Ovarian angiosarcomas are rare and probably arise from
carcinosarcomas, teratomas or the rich ovarian vascula-
ture. The development of a somatic malignancy, more fre-
quently in the form of a sarcoma, is a well-known
phenomenon in a germ cell tumor; however, the patho-
genesis remains unclear. The sarcomatous element may
appear in the primary tumor or manifest in recurrence or
in the metastases. Dedifferentiation phenomenon, malig-
nant transformation of certain mesenchymal elements
within teratomas, origination from primitive germ cellsl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Low power magnification showing ovarian
parenchyma along with the vascular lesion. Hematoxylin and
eosin stain, 10×.
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tumor are some of the proposed theories that have been
put forward in the literature [2,3]. To date, only two small
case series have been published, one with four cases and
the other with seven [4,5]. Approximately 25 percent of
ovarian angiosarcomas are associated with other tumors;
five cases of angiosarcomas arising in mature cystic terato-
mas of the ovary have been described [4-8]. Of the seven
cases of primary ovarian angiosarcoma reported by
Neilson et al. [4], two arose in a dermoid cyst. Two of
the cases of ovarian angiosarcoma were associated with
a coexistent borderline or invasive epithelial neoplasm:
one case with a mucinous cystadenocarcinoma and an-
other with a serous neoplasm of low malignant poten-
tial [9,10]. Recently, cases of angiosarcoma arising in
mucinous cystadenoma and ovarian fibroma have also
been reported [11,12].
Ovarian angiosarcomas are usually unilateral and can
occur at any age (range seven to 81 years, mean
48 years); with rare exceptions it is a disease found in
premenopausal women and most cases are reported in
women of childbearing age (<40 years). Only three cases
have been reported in patients of postmenopausal age
[12]. The most common presenting symptom is abdom-
inal pain, however some patients present with distant
metastases, often in the lungs. Other presenting features
include disseminated intravascular coagulation (DIC)
and combined ascites and pleural effusion. Most of the
reported cases are unilateral, however, bilateral involve-
ment of the ovaries has been recorded.
More than half of the cases were disseminated at the
time of diagnosis and only a few of them were detected
at stage I, with disease progression of less than a year.
Cases of advanced stage disease behave aggressively and
demonstrate poor response to surgery and chemother-
apy, with an overall poor prognosis. Few cases have
shown good response to a regimen of doxorubicin and
ifosfamide.
Case presentation
A 41-year-old Saudi woman, para 7+0, presented to our
gynecological clinic with abdominal pain and abnormal
vaginal bleeding for the last six months. Her menstrual
history was unremarkable. She had a history of a cesarean
section three years previously and appendectomy per-
formed a year ago. On examination, a palpable pelvi-
abdominal mass was detected. Her hemoglobin was 10.1g
and random blood glucose was 80mg. liver and renal func-
tion test results were within normal limits. An ultrasound
study of her abdomen showed a normal-sized uterus dis-
placed to the right side by a left ovarian mass, 8cm at its
maximum dimension. No free fluid was seen. The initial
clinical diagnosis was one of left ovarian cyst. The rest of
her abdominopelvic sonographic examination was normal.Peri-operatively the mass resembled a hemorrhagic solid
tumor. The left ovarian mass was sent for frozen section-
ing, which revealed it was an undifferentiated neoplasm
based on one frozen section; whether it was of benign or
malignant nature could not be ascertained. The final spe-
cimen sent for histopathological examination consisted of
a left salpingo-oophorectomy and incisional biopsy of the
right ovary. Grossly, the left ovarian mass measured
7.0×6.0×2.0cm and was brownish and hemorrhagic, with
solid and cystic areas. Permanent sections of the left ovar-
ian mass showed a vascular neoplasm with adjacent com-
pressed ovarian parenchyma at the periphery (Figures 1
and 2) showing vasoformative arborizing channels of vari-
able sizes and shapes lined by atypical endothelial cells
(Figures 3 and 4). The capsule was intact. Areas of necro-
sis were seen along with fused anastomosing solid vascular
area (Figure 5). The mitotic count was four to five mitotic
figures per 10 high power fields The results of special
stains for glycogen and mucin were negative. No terato-
matous element was identified. The tumor cells tested
positive for CD31 (Figure 6), CD34, factor VIII and
vimentin and negative for cytokeratin AE1/AE3 and low
molecular weight cytokeratin. The proliferative index (Ki-
67) was approximately 20 percent to 30 percent. Our pa-
tient was diagnosed as having an angiosarcoma, inter-
mediate grade, International Federation of Gynecology
and Obstetrics (FIGO) stage IA. A section of the right
ovarian cyst wall showed a benign cyst with inflammation,
extensive hemorrhage and fibroblastic proliferation. The
results of a postoperative investigation for metastatic
disease and evaluation for other possible primary sites
were negative. Our patient was referred to our oncol-
ogy center for further management, and subsequently
lost to follow-up.
Figure 2 Higher magnification of the tumor showing papillary
vascular channels. Hematoxylin and eosin stain, 10×.
Figure 4 High power magnification of well-formed vasoformative
channels showing large pleomorphic nuclei. Hematoxylin and
eosin stain, 40×.
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Sarcomas of the ovary either can be histologically pure
or can represent components of a more complex tumor.
Mature cystic teratoma (MCT) is the most common
type of ovarian neoplasm, accounting for 26.5 percent to
44 percent of all primary ovarian tumors [13]. Malignant
transformation in mature cystic teratoma is rare, seen in
only 0.8 percent to 2 percent of cases, [8,14] and is
mostly represented by squamous cell carcinomas (con-
stituting about 80 percent of secondary somatic malig-
nancies), followed by adenocarcinomas. Other benign
and malignant somatic tumors include melanocytic nevi,
skin adnexal tumors, carcinoids, carcinosarcoma, ma-
lignant melanoma, lymphoma, angiosarcoma, leiomyo-
sarcoma, osteosarcoma, chondrosarcoma, fibrosarcoma,
rhabdomyosarcoma, malignant fibrous histiocytoma and
peripheral neuroectodermal tumor. The behavior of som-
atic malignancies in MCT is not determined by theirFigure 3 Well-formed vasoformative channels. Hematoxylin and
eosin stain, 20×.derivation from germ cells but by their phenotype, and
thus is similar to that of their sporadic counterpart.
The ovary is a common site for metastases and 5 per-
cent to 10 percent of the ovarian malignancies are meta-
static [15]. Details of spread of carcinomas to the ovary
have been reported in the literature, however little infor-
mation regarding the spread and frequency of metastatic
sarcomas to the ovary has been described. Colon cancer
is the most frequent primary malignancy of nongenital
origin that metastasizes to the ovary, and infrequently
gastrointestinal or urological sarcomas metastasize to
the ovary. In 1990, Young and Scully described 21 cases
of metastatic sarcoma relating to the ovaries [16]. The
most common primary sites were the uterine corpus and
cervix (11 of 21 cases). The most common extragenital
primary tumor was leiomyosarcoma of the small intestine,Figure 5 Higher magnification showing solid areas with nuclear
pleomorphism and scattered mitotic figures. Hematoxylin and
eosin stain, 40×.
Figure 6 Tumor cells showing strong immunohistochemical
positivity with CD 31.
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retrovesical leiomyosarcoma, fibrosarcoma of the anterior
abdominal wall, presumed cardiac hemangiosarcoma,
osteosarcoma of the maxilla, chondrosarcoma of the rib,
and Ewing’s sarcoma of the pubic bone. Cases of primary
angiosarcoma of the breast and subcutaneous tissue meta-
static to the ovaries have been recorded [17,18]. In our pa-
tient’s case, no teratomatous element was found despite
adequate sampling.
The presence of sarcoma cells in effusions is an ex-
ceedingly rare finding. Davidson and Abeler [19] re-
ported the first case of a primary ovarian angiosarcoma
with metastatic spread in the peritoneal cavity and para-
aortic lymph nodes, presenting as malignant cells in two
ascitic fluid specimens on immunocytochemistry. Platt
et al. [6] also reported primary angiosarcoma of the
ovary with large volume ascites, but cytological examin-
ation showed no malignant cells.
The microscopic appearance of angiosarcoma can
vary, from focal or diffuse vasoformative components
with dilated, slit-like, papillary or interconnecting vascu-
lar spaces to solid components that may be spindle sar-
comatous or epithelioid. Microcystic/tubulocystic areas,
and fascicular or reticular patterns can be seen. A diag-
nosis may be difficult if the vascular nature of the neo-
plasm is not evident and there are more poorly
differentiated areas exhibiting solid growth patterns. The
solid component can mimic fibrosarcoma, leiomyosar-
coma or malignant fibrous histiocytoma. Immunohisto-
chemically they are positive for endothelial markers
including CD31 and CD34 (can be focally positive or
negative) and factor VIII-related antigen. Focal positivity
for smooth muscle actin, HHF35, pankeratin and epithe-
lial membrane antigen (EMA) can be seen, however des-
min is negative. The superiority of CD31 in terms of
sensitivity and specificity for endothelial cells is well rec-
ognized, with reported sensitivity rates of 80 percentversus 62 percent in vasoformative and poorly vasofor-
mative angiosarcomas, respectively. Angiosarcoma should
be included in a panel in which an endothelial neoplasm
is in the differential diagnosis. Factor VIII-related antigen
is a marker of endothelial cell differentiation and its sensi-
tivity decreases from 84 percent to 29 percent as the
vasoformative areas become more solid and poorly dif-
ferentiated [20].
The differential diagnosis includes hemangioma, epi-
thelioid hemangiomas, infantile hemangioendothelioma
and metastatic angiosarcoma, embryonal carcinoma,
melanoma, poorly differentiated carcinoma and leiomyo-
sarcoma. Pure primary sarcomas other than angiosar-
coma that have been described to occur in the ovary
include fibrosarcoma, rhabdomyosarcoma, leiomyosar-
coma, chondrosarcoma, osteosarcoma, and malignant
peripheral nerve sheath tumor. Benign vascular neo-
plasms of the ovary are uncommon. Case reports of iso-
lated hemangiomas [21] of the ovary have been described,
as well as those associated with generalized hemangioma-
tosis. Subtypes of hemangioma have been reported in the
ovary, including a mitotically active epithelioid vascular
tumor that behaved in a benign fashion [22]. Baker, Rosai,
and Yough [23] reported florid benign vascular prolifera-
tion in ovarian teratomas (MCT and immature teratoma)
that may be confused with a vascular neoplasm probably
induced by growth factors liberated by extensive neural
component seen in these tumors. In general, hemangi-
omas of the ovary are located in the medulla and are of
the cavernous type. Distinction from a malignant mixed
Müllerian tumor is based on the presence of a malignant
epithelial component, as well as its occurrence in an older
population. Poorly differentiated, more solid and spindle-
shaped angiosarcomas may also mimic sarcomatoid
carcinomas on histological evaluation. If close to an
epithelioid malignancy, epithelioid angiosarcoma may
easily be mistaken for a poorly differentiated carcin-
oma. The presence of histologically better differenti-
ated carcinomatous areas, as well as positive staining
for keratin (albeit sometimes only focally) in the sarco-
matoid areas may be helpful. Conversely, immunoposi-
tivity for CD31 or von Willebrand factor would rule
out carcinoma. Cases of angiosarcoma with a more fas-
cicular growth pattern in poorly differentiated areas
may closely mimic other mesenchymal tumors, such as
a leiomyosarcoma. The presence of areas that are sug-
gestive of vascular differentiation may be a helpful
clue; however, distinction relies ultimately on the focal
presence of more typical morphologic features and the
immunohistochemical results. Because of the rarity
and morphologic heterogeneity of ovarian angiosar-
coma, immunopositivity with a specific endothelial
marker (CD31 or von Willebrand factor) is a diagnos-
tic prerequisite.
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determined by their derivation from germ cells but by
their phenotype, and is similar to that of their sporadic
counterparts; therefore, treatment should target the
somatic malignancy rather than the germ cell tumor.
Such malignancies respond poorly to adjuvant chemo-
therapy. The most common chemotherapeutic regimen
used to treat is a combination of doxorubicin and/or
ifosfamide. The combination of mesna, doxorubicin,
ifosfamide and dacarbazine (MAID) chemotherapy has
also been reported, however the efficacy is still uncer-
tain. More than 60 percent of all reported cases of ovar-
ian angiosarcoma were detected at stages III and IV.
They have a tendency for local recurrence and metasta-
ses, and prognosis is poor; the reported five-year survival
rate is 10 percent to 35 percent [24]. The survival for all
cases ranged from 18 days to nine years, however, no
stage III or IV patient with a reported follow-up has sur-
vived more than 30 months. The only exception is in a
patient described by Platt et al. [6], who describes
complete resolution of a stage IV angiosarcoma after five
cycles of MAID chemotherapy. There are seven docu-
mented cases of patients with stage I disease surviving up
to nine years, with one even becoming pregnant [2,4,5,25].
Conclusions
Examination of multiple sections of an ovarian neo-
plasm, use of immunohistochemical studies in cases of
poorly differentiated tumors and awareness of occur-
rence of angiosarcoma in ovary may result in more cases
being identified and reported.
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